Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
dfwl28's Profile
Displaying 51-100 of 833 result(s).
CYDY CytoDyn Inc
05/14/2025 12:05:48 PM
Ohm comment: "...66.6% aren't. What (4)
CYDY CytoDyn Inc
05/13/2025 4:07:52 PM
More inhibitor success in BRCA brea (2)
CYDY CytoDyn Inc
05/13/2025 1:30:04 PM
In MUO this is notable if not big s (6)
CYDY CytoDyn Inc
05/13/2025 8:52:14 AM
VANCOUVER, Washington, May 13, 2025 (2)
CYDY CytoDyn Inc
05/08/2025 8:41:21 AM
Ohm: "You can't fake that they are (8)
CYDY CytoDyn Inc
05/06/2025 9:03:21 AM
Thank You Cassandra. Very, very hel (3)
CYDY CytoDyn Inc
05/05/2025 1:58:13 PM
Hijacked AI excerpt from a post by (4)
CYDY CytoDyn Inc
05/05/2025 1:33:09 PM
Ohm: "A large rise from normal CCR5 (4)
CYDY CytoDyn Inc
05/05/2025 11:03:21 AM
Ken: Thanks for the reply. My first (3)
CYDY CytoDyn Inc
05/05/2025 10:09:03 AM
Interesting Ohm: "... As an example (5)
CYDY CytoDyn Inc
04/11/2025 5:52:29 PM
Excerpt: "Methods: By taking advant (12)
CYDY CytoDyn Inc
04/09/2025 1:32:50 PM
Thanks Ohm Excerpt: "Progression-f (6)
CYDY CytoDyn Inc
04/09/2025 9:33:19 AM
Ohm: "What I'd like to see is leron (4)
CYDY CytoDyn Inc
04/07/2025 8:43:21 PM
That study is from June 2022. Shoul (2)
CYDY CytoDyn Inc
04/03/2025 11:37:36 AM
CYDY is one of the exceptional gree (1)
CYDY CytoDyn Inc
03/26/2025 12:56:04 PM
Thanks Katangolo. It is very helpfu (1)
CYDY CytoDyn Inc
03/26/2025 10:23:24 AM
Can one of the brighter lights here (2)
CYDY CytoDyn Inc
03/24/2025 6:03:20 PM
"Docj Very helpful with complex CTC (3)
CYDY CytoDyn Inc
03/24/2025 1:02:56 PM
Jake: "...it would seem very likely (7)
CYDY CytoDyn Inc
03/24/2025 8:54:15 AM
Jake: " (While the FDA has apparent (3)
CYDY CytoDyn Inc
03/18/2025 10:06:49 AM
Excellent letter. You can virtually (4)
CYDY CytoDyn Inc
03/10/2025 2:56:16 PM
Thanks, My69z. Excellent find. (1)
CYDY CytoDyn Inc
03/05/2025 8:20:06 AM
Paxlovid doesn't work. https://www. (8)
CYDY CytoDyn Inc
03/01/2025 9:36:37 AM
The current CEO used to handle such (4)
CYDY CytoDyn Inc
02/20/2025 11:29:17 AM
Original Article: Clinical Science (6)
CYDY CytoDyn Inc
02/14/2025 4:01:36 PM
Alz and systemic inflammation and L (5)
CYDY CytoDyn Inc
02/11/2025 10:00:30 AM
Surgery or LL for fatty liver disea (1)
CYDY CytoDyn Inc
01/28/2025 5:30:37 PM
Refinitiv accuracy standard 99.85%: (5)
CYDY CytoDyn Inc
01/20/2025 9:11:41 AM
The more - the merrier. (3)
PHIO Phio Pharmaceuticals Corp.
01/14/2025 7:38:57 AM
300% gain https://www.stocktitan.n
CYDY CytoDyn Inc
01/12/2025 12:56:43 PM
My comment to NY Times article on p (18)
CYDY CytoDyn Inc
12/05/2024 4:29:48 PM
Jonah B Sacha, PhD Poster presentat (11)
CYDY CytoDyn Inc
12/03/2024 4:34:20 PM
Glaucoma and the CCR5 connection. E (10)
CYDY CytoDyn Inc
11/29/2024 6:15:05 PM
CCR5/CCL5 axis in human health. Abs (7)
CYDY CytoDyn Inc
11/27/2024 3:45:52 PM
The science is moving our way. Pat (13)
CYDY CytoDyn Inc
11/27/2024 9:11:25 AM
Thank you ohm. An exceptional and v (2)
CYDY CytoDyn Inc
11/25/2024 10:18:46 AM
The enemy of my enemy is my friend. (4)
CYDY CytoDyn Inc
11/25/2024 10:04:09 AM
SAVA down and out 83% pre mkt. No k (3)
CYDY CytoDyn Inc
11/15/2024 5:17:04 PM
Many long COVID patients adjust to (6)
CYDY CytoDyn Inc
11/13/2024 9:59:18 AM
A Randomized Placebo-Controlled Tri (7)
CYDY CytoDyn Inc
11/09/2024 1:40:54 PM
long COVID in 22.8% of patients, a (4)
CYDY CytoDyn Inc
11/08/2024 2:45:20 PM
https://www.globenewswire.com/news (6)
CYDY CytoDyn Inc
11/07/2024 1:43:30 AM
Thanks ohm. Good news. This could e (5)
CYDY CytoDyn Inc
11/06/2024 8:45:24 PM
"...This combination is tailored fo (2)
CYDY CytoDyn Inc
10/28/2024 2:23:30 PM
US vs Nader Pourhassan ***If convic (6)
CYDY CytoDyn Inc
10/25/2024 3:21:06 PM
Stunning group of docs. Thanks for (2)
CYDY CytoDyn Inc
10/25/2024 3:07:17 PM
He sounds like an AI creation/bashe (3)
CYDY CytoDyn Inc
10/20/2024 7:40:41 PM
This is MSK in NYC. 100% remission (7)
CYDY CytoDyn Inc
10/19/2024 8:41:14 PM
Groundbreaking clinical trial achie (9)
CYDY CytoDyn Inc
10/19/2024 9:40:05 AM
An Amarex product. A ton of data po (2)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • LPL Financial Highlights CEO Presentation at Key Industry Event
  • Verano Expands Operations with New License in Texas Market
  • Leslie’s, Inc. Reports Strong Fourth Quarter Results for FY2025
  • Uniti Group Inc. Prepares for Key Conference at Raymond James
  • Tailwind 2.0 Acquisition Moves Forward with Share Trading Plans
  • SPS Commerce to Showcase Innovations at Nasdaq Conference 2025
  • Lee Enterprises Reschedules Special Meeting to Enhance Participation
  • Voting Rights and Total Shares Information for Investors
  • Join Plug Power's Insights at the Asia-Pacific Investor Forum
  • Exciting Advances in Silevertinib from Black Diamond Therapeutics
  • PrairieSky Royalty Announces Dividend for Q4 of 2025
  • Opus Genetics Unveils Inducement Grant for New Employees
  • Embracing the AI Revolution: Security Challenges Ahead
  • Zymeworks Engages in Key Conferences to Showcase Innovations
  • PennantPark Investment Corporation Declares Monthly $0.08 Dividend
  • Red Cat Enhances Leadership Team for Growth and Excellence
  • FibroGen's Participation in Key Rare Disease Summit Announced
  • PennantPark Floating Rate Capital Ltd. Announces New Monthly Distribution
  • Vestand Faces Nasdaq Compliance Challenges Amid Filing Delays
  • Microchip Technology Updates Outlook for Q3 Fiscal 2026 Earnings
  • Experience the Zombie Apocalypse in Outbreak 2: Mall Mayhem
  • Evaluating the Current Market Position of Cigna Group Inc.
  • Charter Communications to Showcase Innovations at UBS Event
  • Function Health Welcomes Ziad Sultan to Lead AI and Technology Growth
  • Microsoft's AI Vision: Ensuring a Balanced Future in Tech
  • Experience the Thrills of Outbreak 2: Mall Mayhem Today
  • Kroll Partners with CrowdStrike to Enhance Cybersecurity Solutions
  • Brand Engagement Network Implements 1-for-10 Stock Split Strategy
  • Exciting Update on LOTIS-7 Clinical Trial by ADC Therapeutics
  • Kroll and CrowdStrike Partner for Enhanced Cybersecurity Services
  • Post Holdings Plans Significant Redemption of Senior Notes
  • Pure Storage Reports Solid Q3 Results, Boosts Fiscal Outlook
  • Zillow Group to Showcase Innovations at Barclays Conference
  • OneStream's Strategic Leadership Transitions for Future Growth
  • Discovering Ziihera: Transforming Cancer Care with Innovation
  • Sunrise New Energy Secures $30 Million Supply Deal for Growth
  • The Impressive Growth of Booking Holdings Stock Unveiled
  • Exploring the Legal Investigation Into Humana, Inc. (NYSE:HUM)
  • Investors of Perrigo Company plc Should Act Before Class Action Deadline
  • Exploring a New Paradigm: Evolution in the Age of AI
  • Long-Term Investment Insights: CACI International's Growth Journey
  • Snowflake Stock Soars Amid Strong Earnings Expectations
  • Investigation into Securities Violations of Jayud Global Logistics
  • Understanding the Skye Bioscience Class Action Lawsuit
  • Asetek Ramps Up Transparency with Major Insider Trade
  • TVA Secures Significant Grant to Propel Nuclear Innovations
  • Exploring the Impact of Venezuela's Oil Revival on Inflation Trends
  • Protest Highlights Concerns Over AI Regulation and Child Safety
  • Sunrise New Energy Expands into Energy Storage with New Contract
  • Investigation of Varonis Systems: Legal Actions and Financial Insights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site